- Home
- NMIH vs SRRK Comparison
NMIH vs SRRK Comparison
Compare NMIH & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMIH
- SRRK
- Stock Information
- Founded
- NMIH 2011
- SRRK 2012
- Country
- NMIH United States
- SRRK United States
- Employees
- NMIH N/A
- SRRK N/A
- Industry
- NMIH Property-Casualty Insurers
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NMIH Finance
- SRRK Health Care
- Exchange
- NMIH Nasdaq
- SRRK Nasdaq
- Market Cap
- NMIH 2.8B
- SRRK 3.1B
- IPO Year
- NMIH 2013
- SRRK 2018
- Fundamental
- Price
- NMIH $37.88
- SRRK $30.67
- Analyst Decision
- NMIH Buy
- SRRK Strong Buy
- Analyst Count
- NMIH 7
- SRRK 6
- Target Price
- NMIH $42.14
- SRRK $42.17
- AVG Volume (30 Days)
- NMIH 850.3K
- SRRK 1.3M
- Earning Date
- NMIH 04-29-2025
- SRRK 05-14-2025
- Dividend Yield
- NMIH N/A
- SRRK N/A
- EPS Growth
- NMIH 14.57
- SRRK N/A
- EPS
- NMIH 4.63
- SRRK N/A
- Revenue
- NMIH $667,964,000.00
- SRRK N/A
- Revenue This Year
- NMIH N/A
- SRRK N/A
- Revenue Next Year
- NMIH $5.10
- SRRK $601.05
- P/E Ratio
- NMIH $8.18
- SRRK N/A
- Revenue Growth
- NMIH 11.61
- SRRK N/A
- 52 Week Low
- NMIH $31.59
- SRRK $6.76
- 52 Week High
- NMIH $42.49
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- NMIH 65.10
- SRRK 47.15
- Support Level
- NMIH $37.19
- SRRK $28.76
- Resistance Level
- NMIH $38.97
- SRRK $33.48
- Average True Range (ATR)
- NMIH 0.88
- SRRK 1.71
- MACD
- NMIH 0.49
- SRRK -0.04
- Stochastic Oscillator
- NMIH 81.47
- SRRK 32.60
About NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.